Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Sales | 0 | 0 | 0 | 0 | -1,080 |
| Cost of Goods | 0 | N/A | N/A | N/A | -860 |
| Gross Profit | 0 | N/A | N/A | N/A | -230 |
| Operating Expenses | 240 | 15,573 | 46 | 68 | -450 |
| Operating Income | -240 | -15,573 | -46 | -68 | -630 |
| Interest Expense | 0 | 0 | 0 | 0 | -30 |
| Other Income | 180 | 27,998 | 34 | 27 | 230 |
| Pre-tax Income | -60 | 12,425 | -12 | -41 | -370 |
| Net Income Continuous | -60 | 12,425 | -12 | -41 | -370 |
| Net Income | $-60 | $12,425 | $-12 | $-41 | $-370 |
| EPS Basic Total Ops | -2.00 | 0.00 | 0.00 | -1.00 | N/A |
| EPS Basic Continuous Ops | -317.18 | 315.84 | -0.30 | -0.99 | N/A |
| EPS Diluted Total Ops | -2.00 | 0.00 | 0.00 | -1.00 | N/A |
| EPS Diluted Continuous Ops | -317.18 | 315.84 | -0.30 | -0.99 | N/A |
| EBITDA(a) | $-240 | $-15,573 | $-46 | $-68 | $-570 |